FDA’s Juul Approval Sparks Outrage from Lawmakers
The U.S. Food and Drug Administration’s (FDA) recent decision to grant marketing authorization to several Juul Labs e-cigarette products has ignited sharp condemnation from leading Democratic lawmakers, who are calling the move a dangerous step backward in the fight against the youth vaping epidemic. U.S. Senate Democratic Whip Dick Durbin (D-IL) and Congressman Raja Krishnamoorthi (D-IL) both released scathing statements, accusing the FDA under the Trump administration of prioritizing “Big Tobacco” over children’s health and vowing to investigate the circumstances of the decision.
The FDA’s authorization allows Juul to resume selling its original devices along with its tobacco and menthol-flavored pods in the U.S. market. This reverses a 2022 marketing denial order and comes despite Juul’s history of being at the center of the youth vaping crisis and paying nearly $1 billion to states for its misleading promotional practices.
Senator Durbin, a long-time critic of the tobacco industry, slammed the decision. “For years, I have sounded the alarm on the dangers of the youth vaping epidemic… Juul ignited this epidemic by addicting millions of children, and lied about the harms of their vapes,” Durbin stated. “Despite this shameful history, FDA ignored JUUL’s disqualifying conduct, unleashing a wave of disease and addiction on America’s children. It is clear that the Trump Administration does not care about our kids. Instead, they are giving the green light to Big Tobacco to continue lining their pockets by peddling poison.” Durbin announced he would be launching an investigation into the “troubling circumstances” of the ruling and called on FDA Commissioner Marty Makary to “immediately reverse this decision.”
Congressman Krishnamoorthi, co-founder of the bipartisan Congressional Caucus to End the Youth Vaping Epidemic, echoed these sentiments. “Juul helped ignite the youth vaping epidemic, and the FDA’s decision to reauthorize its products—including menthol-flavored vapes popular with kids—is a profound mistake,” said Krishnamoorthi. “This ruling is a clear win for Big Tobacco and undermines years of bipartisan work to get these addictive products off the market.”
Both lawmakers highlighted their extensive history of pushing for stricter enforcement and regulation of e-cigarettes. Durbin has repeatedly criticized the FDA for its “continued lack of urgency” and failure to properly enforce the Tobacco Control Act’s premarket authorization requirements. Krishnamoorthi, who launched the first congressional investigation into Juul’s marketing tactics in 2019, has recently focused on cracking down on illicit flavored vapes from China and has called on the FDA to strengthen enforcement against the thousands of unauthorized flavored products that remain on the market and appeal to children. The lawmakers’ unified opposition signals a potential for intense congressional scrutiny of the FDA’s decision-making process regarding e-cigarette authorizations.
- South Korea Escalates Tobacco Warnings with Blunt, Fatalistic Labels - June 22, 2026
- Magnolia Commissioner Proposes Ordinance to Ban Vape Shops - June 22, 2026
- Belarus Moves to Ban Vape and E-Cigarette Advertising Under New Bill - June 22, 2026
